Clinical trials to determine the safety and efficacy of a COVID-19 vaccine candidate from US biotech company Novavax have begun in the US and Mexico, the National Institutes of Health (NIH) said on Monday. United States. A similar Phase 3 study for the same vaccine called NVX-CoV2373 is also ongoing in the UK, where around 15,000 volunteers have been recruited. In the United States and Mexico, the new studies will enroll approximately 30,000 volunteers over the age of 18. Two-thirds of the participants receive the vaccine and one-third a placebo. None of them will know what was in the injection they were given during the test. “The start of this trial – the fifth experimental COVID-19 vaccine candidate to be tested in a Phase 3 trial in the US – shows our determination to end the pandemic by developing several safe and effective vaccines,” he said Fauci, director of the National Institute for Allergies and Infectious Diseases (NIAID), which is part of the NIH.
Practically a large portion of 1,000,000 Americans contracted COVID-19 in past week as diseases flood
Chicago: Nearly a large portion of 1,000,000 individuals in the United States have gotten the novel Covid over the most recent seven days, as indicated by a Reuters count, as cases and hospitalizations set new …………[Read more]
Billionaire investor Chamath Palihapitiya says the GameStop rally was no different than Wall Street missed Tesla’s rise to power
Investor Chamath Palihapitiya told CNBC on Wednesday that the GameStop rally looked like Tesla’s rise. GameStop’s unprecedented market surge, led by Reddit, has mirrored Tesla’s rally for years, billionaire Chamath Palihapitiya told CNBC on Wednesday. …………[Read more]
Scholarship Description: The NSERC Postdoctoral Fellowships Program, 2019, is only open to Canadian citizens. The scholarship enables postdoctoral programs in electrical engineering, physics, chemistry, astronomy, and mechanical engineering taught at the Natural Sciences and Engineering …………[Read more]